Angiogenesis inhibitors are a standard first-line treatment for metastatic colorectal cancer. Anal canal pain is a common adverse event, but its cause has never been described. The aim of the study was to evaluate the association between the use of angiogenesis inhibitors and symptomatic anal ulcer development.

Angiogenesis inhibitors and symptomatic anal ulcers in metastatic colorectal cancer patients *

Castoro, Carlo;
2018

Abstract

Angiogenesis inhibitors are a standard first-line treatment for metastatic colorectal cancer. Anal canal pain is a common adverse event, but its cause has never been described. The aim of the study was to evaluate the association between the use of angiogenesis inhibitors and symptomatic anal ulcer development.
Adult
Aged
Angiogenesis Inhibitors
Bevacizumab
Cohort Studies
Colorectal Neoplasms
Female
Fissure in Ano
Humans
Male
Middle Aged
Retrospective Studies
File in questo prodotto:
File Dimensione Formato  
Angiogenesis inhibitors and symptomatic anal ulcers in metastatic colorectal cancer patients.pdf

non disponibili

Tipologia: Versione Editoriale (PDF)
Licenza: Copyright dell'editore
Dimensione 1.57 MB
Formato Adobe PDF
1.57 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11699/48076
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact